More PRNewswire
View Older Stories View Newer Stories-
YS Biopharma Announces Name Change to LakeShore Biopharma
-
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
-
XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched
-
Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform
-
Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
-
HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
-
Matt Epstein Joins Travelzoo's Global Executive Team
-
Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress
-
AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting
-
THE CATO CORPORATION ANNOUNCES REGULAR QUARTERLY DIVIDEND
-
Alma Unveils Alma Harmony™ and Alma IQ™ in U.S. Market, Advancing Personalization in Aesthetic Treatments
-
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
-
PathKeeper Surgical Selected to Exhibit at Vizient Innovative Technology Exchange
-
GOTRAX Introduces New Fat Tire Electric Bike, the Alpine
-
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO)
-
Air Premia, Celebrates the First Anniversary of Its New York Route with Exceptional Performance
-
61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreak
-
Quanta Services Announces Quarterly Cash Dividend
-
LYB Announces 7 Percent Increase to Quarterly Dividend
-
Bybit Web3 Announces Upcoming IDO for Aperture Finance, Simplifying Web3 Finance
-
ARCHIPELAGO INTERNATIONAL CONTINUES EXPANSION IN THE CARIBBEAN AND LATIN AMERICA WITH PLANNED NEW OPENINGS, MULTIPLE SIGNINGS AND NEW CORPORATE OFFICES IN PUNTA CANA
-
K-Pet develops disease prevention solutions to extend the healthy life of pets
-
Arriving in 2026: U-Haul to Build 800-Room Self-Storage Facility in North Buford
-
Weekly Recap: 13 Press Releases You Might Have Missed
-
36Kr Hosts "AI Partner • Advanced Productivity" Conference
-
Gateway Foundation Announces Grant Funding Opportunity Following Closure of Historic Beacon House
-
Dutch Bros raises $2.5M for the Muscular Dystrophy Association
-
Atour Unveils Sustainability Records in 2023 With Milestone ESG Report
-
CNFinance to Hold Annual General Meeting on June 7, 2024
-
Lights On! Harbour City transforms for Vivid Sydney 2024
-
Alchemy Pay Now Offers Fiat On-Ramp for stETH on Lido
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
-
New Study Shows DigeSEB Super™ Enhances Digestion
-
New Oriental Extends Share Repurchase Program
-
XData Group Introduces Enhanced Website and Refreshed Brand Image
-
SiteSense® Mobile Materials Management by Intelliwave for SAP® S/4HANA is Now Available on SAP® Store
-
Epsilor is Proud to Announce that it has been chosen by RAFAEL to Develop and Produce the Multi-Charger Rack (MCR) for the SPIKE SR and SPIKE LR Launchers' Batteries
-
JPA HEALTH EXPANDS CAPABILITIES WITH THE ACQUISITION OF BIOCENTRIC, INC.
-
Notification of major holding in Kindred Group plc
-
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor
-
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
-
Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region
-
STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024
-
Innomix Ushers in a New Age of LBMR Immersive Experiences
-
Dance Drama Wing Chun Captivates at China's Top Cultural Fair, Eyes European Debut
-
Starbreeze brings the full 1.0 release of 'The Tribe Must Survive'
-
The9 Obtained Strategic Investment from Fine Vision Game Fund
-
The9 Obtained Exclusive Publishing License of "MIR M" IP, A New Chinese Edition of Mobile and PC Game from Wemade
-
Global Times: Creating a way for 'Jasmine' to bloom along the 'Moon River'
-
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology Company

